Not a good buy right now: price is sitting just below near-term resistance (35.30) with limited upside room versus downside to first support (32.49).
Trend is generally bullish (stacked moving averages), but momentum is not confirming (MACD histogram still below zero).
Options positioning is call-heavy (bullish sentiment), yet actual volume is very light—signal strength is limited.
With deteriorating YoY earnings/revenue in the latest reported quarter and a statistically negative 1-month pattern bias, the risk/reward today is not attractive for an impatient entry.
Technical Analysis
Trend: Bullish moving-average structure (SMA_5 > SMA_20 > SMA_200) suggests the broader trend is up.
Momentum: MACD histogram at -0.0985 (below 0) = momentum is still bearish/lagging, though it is contracting (downtrend pressure easing).
RSI: RSI_6 = 61.18 (neutral-to-slightly bullish), not overbought, but not a strong “washout” entry either.
Levels: Pivot 33.89. Resistance R1 35.30 (nearby). Support S1 32.49.
Upside to R1 from 34.46: ~+2.4%
Downside to S1 from 34.46: ~-5.7%
This skew makes the immediate entry less favorable.
Pattern-based odds: Similar-pattern projection implies ~+2.38% over a week, but -5.93% over a month, which weakens the case for buying immediately.
Net income: $3.75M, down sharply YoY (reported -304.31% YoY).
EPS: $0.28, down sharply YoY (reported -300.00% YoY).
Gross margin: 19.87%, +47.84% YoY (cost/mix improvement), but it did not translate into stronger bottom-line growth YoY.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating or price target change data was provided in the dataset, so a recent Wall Street upgrade/downgrade trend cannot be confirmed.
With available information, the pro view would hinge on improving margins and the uptrend; the con view would focus on declining revenue/EPS and weak momentum confirmation.
Wall Street analysts forecast IPI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPI is 24 USD with a low forecast of 24 USD and a high forecast of 24 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast IPI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPI is 24 USD with a low forecast of 24 USD and a high forecast of 24 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
0 Hold
2 Sell
Moderate Sell
Current: 31.690
Low
24
Averages
24
High
24
Current: 31.690
Low
24
Averages
24
High
24
UBS
Sell
maintain
$21 -> $24
AI Analysis
2025-07-23
Reason
UBS
Price Target
$21 -> $24
AI Analysis
2025-07-23
maintain
Sell
Reason
UBS raised the firm's price target on Intrepid Potash to $24 from $21 and keeps a Sell rating on the shares.
UBS
Joshua Spector
Strong Sell
Maintains
$20 → $19
2025-04-16
Reason
UBS
Joshua Spector
Price Target
$20 → $19
2025-04-16
Maintains
Strong Sell
Reason
UBS lowered the firm's price target on Intrepid Potash to $19 from $20 and keeps a Sell rating on the shares as part of a Q1 North American fertilizers group review and preview note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IPI
